Acadian Asset Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-449
| Closed | -$18K | – | 1990 |
|
|
2024
Q3 | $18K | Buy |
+449
| New | +$18K | ﹤0.01% | 1991 |
|
|
2023
Q1 | – | Sell |
-1,059
| Closed | -$10K | – | 1888 |
|
|
2022
Q4 | $10K | Hold |
1,059
| – | – | ﹤0.01% | 1739 |
|
|
2022
Q3 | $13K | Buy |
+1,059
| New | +$13K | ﹤0.01% | 1626 |
|
|
2022
Q2 | – | Sell |
-385
| Closed | -$14K | – | 1804 |
|
|
2022
Q1 | $14K | Sell |
385
-785
| -67% | -$28.5K | ﹤0.01% | 1590 |
|
|
2021
Q4 | $112K | Buy |
+1,170
| New | +$112K | ﹤0.01% | 1353 |
|
|
2020
Q3 | – | Sell |
-802
| Closed | -$266K | – | 2295 |
|
|
2020
Q2 | $266K | Sell |
802
-13,080
| -94% | -$4.34M | ﹤0.01% | 1397 |
|
|
2020
Q1 | $3.16M | Sell |
13,882
-10,005
| -42% | -$2.28M | 0.02% | 480 |
|
|
2019
Q4 | $5.89M | Sell |
23,887
-6,596
| -22% | -$1.63M | 0.03% | 406 |
|
|
2019
Q3 | $1.74M | Buy |
30,483
+308
| +1% | +$17.6K | 0.01% | 725 |
|
|
2019
Q2 | $1.42M | Hold |
30,175
| – | – | 0.01% | 714 |
|
|
2019
Q1 | $1.63M | Buy |
30,175
+5,468
| +22% | +$295K | 0.01% | 740 |
|
|
2018
Q4 | $1.07M | Buy |
24,707
+5,497
| +29% | +$238K | 0.01% | 720 |
|
|
2018
Q3 | $1.13M | Buy |
+19,210
| New | +$1.13M | ﹤0.01% | 696 |
|
|
2018
Q2 | – | Sell |
-88
| Closed | -$25K | – | 1795 |
|
|
2018
Q1 | $25K | Buy |
+88
| New | +$25K | ﹤0.01% | 1465 |
|